Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

2.

Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension.

Anan F, Takahashi N, Ooie T, Yufu K, Hara M, Nakagawa M, Yonemochi H, Saikawa T, Yoshimatsu H.

Eur J Clin Pharmacol. 2005 Jul;61(5-6):353-9. Epub 2005 May 26.

PMID:
15918057
3.

Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.

Lacourcière Y, Béliveau R, Conter HS, Burgess ED, Lepage S, Pesant Y, Spence JD, Asmar R, Carrière S, Plante GE; Canadian Hypertension Society.

Can J Cardiol. 2004 Jun;20(8):795-9.

PMID:
15229761
4.

Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.

Protogerou A, Blacher J, Stergiou GS, Achimastos A, Safar ME.

J Am Coll Cardiol. 2009 Feb 3;53(5):445-51. doi: 10.1016/j.jacc.2008.09.046.

5.

Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension.

Pannier BM, Guerin AP, Marchais SJ, London GM.

Clin Exp Pharmacol Physiol. 2001 Dec;28(12):1074-7.

PMID:
11903319
6.

Angiotensin II receptor blocker prevents increased arterial stiffness in patients with essential hypertension.

Agata J, Nagahara D, Kinoshita S, Takagawa Y, Moniwa N, Yoshida D, Ura N, Shimamoto K.

Circ J. 2004 Dec;68(12):1194-8.

7.

[Pulse wave velocity and urinary albumin excretion in hypertensive patients treated with perindopril].

Toblli JE, Bellido CA, Iavícoli OR, Costa M, Forcada P, Piñeiro DJ, Lerman J.

Medicina (B Aires). 2002;62(6):544-50. Spanish.

PMID:
12532688
8.

Influence of the Angiotensin II type I receptor gene 1166A > C polymorphism on BP and aortic pulse wave velocity among Malays.

Rehman A, Rasool AH, Naing L, Roshan TM, Rahman AR.

Ann Hum Genet. 2007 Jan;71(Pt 1):86-95.

9.

ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.

Fogari R, Zoppi A, Lazzari P, Preti P, Mugellini A, Corradi L, Lusardi P.

J Cardiovasc Pharmacol. 1998 Oct;32(4):616-20.

PMID:
9781930
10.
11.
12.

Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients.

Benetos A, Gautier S, Ricard S, Topouchian J, Asmar R, Poirier O, Larosa E, Guize L, Safar M, Soubrier F, Cambien F.

Circulation. 1996 Aug 15;94(4):698-703.

13.

Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients.

Fogari R, Mugellini A, Zoppi A, Corradi L, Preti P, Lazzari P, Derosa G.

Am J Hypertens. 2002 Apr;15(4 Pt 1):316-20.

PMID:
11991216
14.

Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension.

Erdem Y, Usalan C, Haznedaroğlu IC, Altun B, Arici M, Yasavul U, Turgan C, Cağlar S.

Am J Hypertens. 1999 Nov;12(11 Pt 1):1071-6.

PMID:
10604482
15.
16.

Assessment of perindopril's efficacy on arterial distensibility in mild to moderate hypertension.

[No authors listed]

J Med Assoc Thai. 2001 Jul;84(7):1006-14.

PMID:
11759959
17.

Angiotensin II type 1 receptor-153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects.

Lajemi M, Labat C, Gautier S, Lacolley P, Safar M, Asmar R, Cambien F, Benetos A.

J Hypertens. 2001 Mar;19(3):407-13.

PMID:
11288810
18.
19.

Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients.

Ichihara A, Hayashi M, Kaneshiro Y, Takemitsu T, Homma K, Kanno Y, Yoshizawa M, Furukawa T, Takenaka T, Saruta T.

Am J Kidney Dis. 2005 May;45(5):866-74.

PMID:
15861352
20.

Supplemental Content

Support Center